Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04524260
Other study ID # PAINT - Zurich
Secondary ID 2019-00643SNCTP0
Status Recruiting
Phase N/A
First received
Last updated
Start date August 31, 2020
Est. completion date February 28, 2023

Study information

Verified date February 2021
Source University of Zurich
Contact Eva Breuer, MD
Phone 0041 43 253 78 26
Email eva.breuer@usz.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators want to study whether the use of painting art therapy has an influence on the quality of life, the complication rate and the general outcome of major abdominal surgery. The painting art therapy is carried out according to the protocol of (LOM® Solution Centered Art Therapy) by trained painting art therapists.


Description:

The interest in alternative and complementary medical treatments has increased significantly in recent years and several studies showed a positive effect on the healing process of patients undergoing surgery. Painting art therapy represents another possible form of such a complementary medical treatment. However, the effect in the context of major abdominal surgical interventions has not yet been investigated, which is why the investigators are conducting this study. Selected patients referred to the Department of Visceral and Transplantation Surgery with operable pathologies of the pancreatic and the lower gastrointestinal tract are subjected to perioperative painting art therapy. It is carried out according to the protocol of (LOMĀ® Solution Centered Art Therapy) by trained painting art therapists. The investigators want to evaluate the effectiveness of perioperative painting art therapy by analyzing the results of several questionnaires regarding anxiety and depression levels as well as health related patient data to observe the short/long term outcome and the psychological well-being of patients undergoing major surgery in case of carcinoma. The aim of the study is to assess if painting art therapy, more precisely the LOMĀ®-method, is effective in reducing symptoms of anxiety and depression in patients undergoing surgery. When it appears that the application of perioperative painting art therapy has a major influence on the postoperative outcome in cancer patients, some patients could benefit from a noninvasive, low-risk and easy additional treatment option. This study is a collaboration with the Institute of Complementary and Integrative medicine of the University Hospital Zurich.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date February 28, 2023
Est. primary completion date August 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Consecutive adult patients of both genders = 18 years subjected to major (oncological) surgery due to pathologies of the pancreatic and lower gastrointestinal tract at our department. - The initial diagnosis does not date back longer than 6 months prior the planned surgery. Neoadjuvant radio-/chemotherapy is not an exclusion criteria. - Able to speak and understand German or English - Signed written informed consent by the participant after extensive oral and written information about the research project and its aims. - Thresholds of primary outcome: anxiety levels measured with STAI-form Y-1 (state) and Y-2 (trait). Thresholds: scores between 20 (minimum) and 80 (maximum) in each subscore. Exclusion Criteria: - Woman who are pregnant or breast feeding. - Known or suspected non-compliance regarding the execution of painting art therapy and/or the proper completion of the needed forms. - Drug or alcohol abuse. - Regular intake of antidepressant medication with the exception of medication prescribed for chronic insomnia. - Acute suicidality. - Life expectancy less than 9 months after planned surgery. - Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, ect. of the participant - Participation in another study during the present study and within 6 weeks following the surgery. - Previous enrollment into the current study. - Enrollment of the investigator, his/her family members, employees and other dependent persons.

Study Design


Intervention

Behavioral:
perioperative painting art therapy (LOM® solution centered art therapy)
We plan to apply painting art therapy as a health-related intervention to patients coming to our department for elective major surgery of the pancreatic and lower gastrointestinal tract for malignant pathologies. Patients will have 3 patient art therapy sessions: one before surgery, one on day 3-5 after surgery during the hospital stay and one during the follow-up 6 weeks postoperative
perioperative painting art therapy (LOM® solution centered art therapy) - control
"usual care", no particular intervention during the perioperative setting. There will be 2-3 painting art therapy sessions after the follow-up 6 weeks postoperative. Therefore this group is called "usual care"- or delayed intervention group.

Locations

Country Name City State
Switzerland Department of Visceral- and Transplantation Surgery, University Hospital Zurich Zurich ZH

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Other Change of Postoperative Pain 1 Subjectively perceived (NRS 0-10) Change from Baseline (NRS pain 0-10) at 6 months post surgery
Other Change of Postoperative Pain 2 Amount of Analgesia (data) Change from Baseline (amount of analgesia) at 6 months post surgery
Other Change of Blood pressure Systolic and diastolic BP in mmHg Change from Baseline at 6 months post surgery
Other Change of Heart Rate HR in bpm (beats per minute) Change from Baseline at 6 months post surgery
Other Change of Respiratory Rate RR/min Change from Baseline at 6 months post surgery
Other Laboratory result, chemistry (CRP) C-reactive protein (mg/l) Change from Baseline at 6 months post surgery
Other Laboratory result, hematology (Hb) Hemoglobin, measured in g/l Change from Baseline at 6 months post surgery
Other Laboratory result, hematology (Leucocytes, White Blood Cells) WBCs measured in G/l Change from Baseline at 6 months post surgery
Other Complications (Clavien-Dindo-Classification) Clavien-Dindo-Classification (classified from 0 - V), higher numbers according to more severe complications, V is dead) 6 months
Other Complications (CCI during hospital stay) CCI during hospital stay; measured from healthy (0) to death (100) 6 months
Other Tumor staging assessed according official TNM-Staging TNM-Classification of Malignant Tumors, 8th edition 1 week postoperative (as soon as final histopathology is available)
Other Socio-economic: days in hospital Days in hospital until discharge, measured in days up to 6 months post surgery
Other Socio-economic: days in ICU Days in ICU until discharge to regular unit, measured in days up to 6 months post surgery
Other Socio-economic: ability to return to work Measured will be the time from surgery until return to work, in weeks up to 6 months post surgery
Primary Change of Anxiety State Trait Anxiety Inventory, STAI-forms Y-1/state and Y-2/trait (questionnaire), scores range from 20 to 80, with higher scores correlating with greater anxiety Change from Baseline STAI-Score up to 6 months post surgery
Secondary Change of Depression PHQ-9 ("Brief Patient Health Questionnaire-9"), scores ranging from 0 to 27, with higher scores correlating with greater depression Change from Baseline PHQ-9-Score up to 6 months post surgery
Secondary Change of Quality of Life - PROMIS 29 PROMIS 29 ("Profile Physical and Mental Health Summary Scores"-questionnaire), scores ranging from 28 to 150, with higher scores correlating with lower quality of life Change from Baseline PROMIS 29-Scores up to 6 months post surgery
Secondary Change of Health related quality of life - SF-12 SF-12 ("short form 12", 12 question survey), results calculated with scoring programme, with higher scores correlating with lower quality of life Change from Baseline SF-12-Scores up to 6 months post surgery
See also
  Status Clinical Trial Phase
Completed NCT03384706 - A Comparison of CPT Versus ART Versus WL N/A
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03129204 - Sensation Awareness Focused Training for Spouses N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Completed NCT05113277 - Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention N/A
Recruiting NCT05327504 - Written Exposure Therapy for Veterans With SUD and PTSD N/A
Recruiting NCT05843695 - Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety N/A
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Completed NCT00644423 - Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD) N/A
Completed NCT02989987 - NET for SGBV Survivors in Eastern DR Congo N/A
Completed NCT02320799 - Randomized Controlled Trial of Interpersonal Psychotherapy for Depression and PTSD Among HIV+ Women in Kenya N/A
Recruiting NCT02293291 - Thermal Clinic Treatment in Gulf War Illness Phase 1/Phase 2
Completed NCT02242136 - Treatment of Posttraumatic Stress Disorder and Aggressive Behavior in Soldiers and Ex-combatants N/A
Completed NCT02720497 - The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD N/A
Completed NCT01911585 - Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure N/A
Completed NCT01693978 - Contingency Outcomes in Prolonged Exposure N/A
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Completed NCT01469754 - Longitudinal Survey Analysis in Lymphoma Survivors N/A
Completed NCT02362477 - Telemental Health and Cognitive Processing Therapy for Female Veterans With Military-related PTSD Phase 3
Terminated NCT01239173 - Emotional Memory Reactivation in Posttraumatic Stress Disorder Phase 3